Physician profile
Daniel Evans
NPI 1154987600
$4,273.88
in general payments reported to CMS, 2019-2025
29 companies · $2,846 in 2025
The $2,846 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $394 · 2023: $249 · 2024: $785 · 2025: $2,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097 · Education: $1,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,097.02 |
| Education | $1,782.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2025 | |
| Boston Scientific Corporation | $463.27 | 2022-2025 | Axonics, Lynx System, Lithovue |
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Sumitomo Pharma America, INC. | $294.98 | 2024-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $255.85 | 2024 | Axonics |
| Pfizer INC. | $230.53 | 2024-2025 | |
| Janssen Biotech, INC. | $166.75 | 2024-2025 | Erleada, Akeega, Balversa |
| Medtronic, INC. | $119.20 | 2024-2025 | Interstim |
| Olympus America INC. | $98.88 | 2025 | Itind System |
| Accord Healthcare, INC. | $90.56 | 2024-2025 | |
| Teleflex LLC | $84.44 | 2022-2025 | Urolift, Barrigel |
| Progenics Pharmaceuticals, INC. | $76.72 | 2024-2025 | |
| Convatec INC. | $60.15 | 2024 | |
| Laborie Medical Technologies Corp. | $52.43 | 2025 | |
| Merck Sharp & Dohme LLC | $49.73 | 2024 | Keytruda, Welireg |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $49.46 | 2025 | |
| Telix Pharmaceuticals | $48.85 | 2024 | Illuccix |
| Endo USA, INC. | $46.20 | 2025 | Aveed, Xiaflex |
| Antares Pharma, INC. | $45.43 | 2025 | Xyosted |
| Urogen Pharma, INC. | $43.21 | 2025 | |
| Immunitybio, INC. | $27.45 | 2025 | |
| Calyxo, INC. | $23.59 | 2024 | Cvac Aspiration System |
| Coloplast Corp | $23.42 | 2025 | |
| Verity Pharmaceuticals INC. | $23.00 | 2025 | Tlando |
| Ferring Pharmaceuticals INC. | $22.29 | 2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $20.26 | 2025 | |
| Endo Pharmaceuticals INC. | $19.73 | 2022 | |
| Photocure INC | $16.30 | 2024 | Cysview |
| Procept Biorobotics Corporation | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.